Page 2 - Best Immunotherapy for breast cancer doctors: TOP 49 doctors

Prof. Elke Jaeger is one of Germany's top oncologists according to Focus rating, specializing in sarcoma and breast cancer immunotherapy at Nordwest Clinic.

• Head of Oncology and Hematology at Nordwest Clinic
• 41 years of experience of experience in oncology
• Recognized as a top sarcoma specialist

Director of oncology hospitalization at Tel Aviv Medical Center – Dr. Stepfansky leads immunotherapy research and treatment.

• Over 26 years of experience specializing in oncology
• Primary researcher in phase 1-3 clinical trials
• Trained at Ichilov Hospital's renowned oncology department
• Board-certified in both internal medicine and oncology

Prof. Köstler specializes in breast cancer immunotherapy, combining over 22 years of experience of clinical experience with cutting-edge research at Wiener Privatklinik.

• Expert in targeted therapies and personalized cancer medicine
• Associate Professor at Medical University of Vienna
• Focuses on biomarker development and resistance mechanisms
• Published in leading international oncology journals

Dr. Amir specializes in immunotherapy for breast cancer, including targeted therapy with Keytruda (Pembrolizumab). His work includes over 30 presentations at scientific meetings.

• Recipient of ESMO Breast Cancer Translational Research Award
• Fellowship in Breast Cancer Research at Emory University
• Member of European Society of Medical Oncology (ESMO)
• Published researcher with multiple Best Paper awards

Specializes in breast, lung, and gastrointestinal cancers – Dr. Ozatli brings a focused approach to immunotherapy at Istinye Liv University Hospital.

• Associate Professor since 2016, recognized for expertise
• Treats complex cases at leading oncology center
• Background in multiple Turkish oncology departments
• Trained at Selcuk University's Faculty of Medicine

Professor Cemil Bilir specializes in medical oncology with international training at Cleveland Clinic and Northeastern University.

• Over 21 years of experience of experience in medical oncology
• Trained in the U.S. at prestigious institutions
• Member of ASCO and ESMO
• Currently serves as a professor at Sakarya University
• PhD candidate in inorganic chemistry, enhancing treatment approaches

Dr. Alemdar specializes in medical oncology with a focus on breast cancer immunotherapy at Medical Park Antalya Hospital Complex.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Trained at Akdeniz University, a leading institution in Turkey
• Worked at multiple prestigious hospitals including Akdeniz University Hospital

Expert in oncoplastic breast surgery and ROLL/SLNB techniques – Dr. Zengel brings precision to breast cancer care at Medicalpoint International Hospital.

• 12 years of experience of experience in breast surgery and oncology
• Specializes in skin and breast-conserving mastectomies with reconstruction
• Associate Professor of General Surgery with a doctorate in Basic Oncology
• Member of multiple professional associations including Izmir Breast Diseases Association

Professor of Medical Oncology at Trakya University, specializing in breast cancer immunotherapy for over 29 years of experience.

• Fellowship-trained in medical oncology at Trakya University
• Associate Professor and then Professor of Medical Oncology from 2010 to present
• Extensive experience in treating breast cancer with immunotherapy

Assoc. Prof. Atakan Topcu, M.D. specializes in targeted therapies and immunotherapy for breast cancer at Medipol Acibadem District Hospital.

• Published over 50 scientific articles in oncology
• Member of European Society for Medical Oncology (ESMO)
• Expertise in geriatric oncology and cancer-related malnutrition
• Fellowship-trained at Bezmialem Vakıf University

Associate Professor Nail Paksoy is a medical oncologist specializing in breast cancer immunotherapy at Medipol Bahçelievler Hospital, with extensive involvement in international clinical trials.

• ESMO Board Certified in Medical Oncology since 2022
• Participated in 8 international clinical trials, including studies on HER2-positive breast cancer
• Published multiple research papers on breast cancer treatments and outcomes
• Specializes in immunotherapy approaches and targeted therapies

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Ercan Ozden specializes in immunotherapy for breast cancer at VM Medical Park Pendik Hospital, with extensive training in medical oncology.

• Graduated from Istanbul University, Cerrahpaşa Faculty of Medicine
• Completed internal medicine residency at the same institution
• Subspecialized in medical oncology at Kocaeli University Faculty of Medicine
• Practiced internal medicine at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital

Prof. Atci specializes in medical oncology with focused research on immunotherapy for breast cancer at Liv Hospital Topkapı.

• Published 19+ peer-reviewed studies on breast cancer treatments
• Member of American Society of Clinical Oncology (ASCO)
• Associate Professor of Medical Oncology at İstinye University
• Education Coordinator for Medical Oncology Sub-Branch

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Assoc. Prof. Ayse Irem Yasin specializes in immunotherapy for breast cancer at Medipol Acibadem District Hospital, with training from top institutions worldwide.

• ESMO Board Certified – a mark of excellence in oncology
• Trained at University of Piemonte Orientale's Breast Cancer Unit in Italy
• Holds a fellowship in Medical Oncology from Bezm becialem American Vakif University
• Worked at Şişli Etfal Training and Research Hospital

Leading researcher in breast cancer subtypes – Dr. Prat focuses on translating lab findings into personalized immunotherapy approaches at Hospital Quiron Barcelona.

• Heads Translational Genomics Group at IDIBAPS
• President of SOLTI – designs clinical trials for novel breast cancer treatments
• Pioneer in gene expression analysis for tailored therapies
• Co-founded Reveal Genomics – holds three patents in cancer research